San Antonio, TX, United States of America

Victoria Garza

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: C4 Therapeutics, Inc., C4 Therapeutlcs, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Garza. Retrieved from https://idiyas.com/inventor/victoria-garza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 12.2

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Victoria Garza: Innovator in Cancer Treatment

Introduction

Victoria Garza is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative work. Her research focuses on developing compounds that specifically target and degrade BRAF, a protein involved in various cancers.

Latest Patents

Victoria holds a patent for BRAF degraders. This present invention provides compounds that cause the specific degradation of BRAF. The compounds are particularly useful for the treatment of various cancers, showcasing her commitment to advancing medical science.

Career Highlights

Victoria is currently employed at C4 Therapeutics, Inc., where she continues her groundbreaking research. Her work has the potential to change the landscape of cancer treatment, offering new hope to patients.

Collaborations

Victoria collaborates with talented individuals such as Fabienne Ricklin and Christopher G Nasveschuk. These partnerships enhance her research efforts and contribute to the development of innovative solutions in cancer therapy.

Conclusion

Victoria Garza is a dedicated inventor whose work in developing BRAF degraders represents a significant advancement in cancer treatment. Her contributions are paving the way for new therapeutic options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…